Online link to source site
News offline code
True news - The journalist who made the decision: S25_gr05
The CNN article from May 16, 2025, reports that the U.S. Food and Drug Administration (FDA) has officially approved the first-ever blood test to help diagnose Alzheimer’s disease. The test is called Lumipulse and was developed by Fujirebio Diagnostics. This information is true. The article is not fake news because it has been confirmed by multiple independent and reliable sources, including Reuters, the Associated Press, and The Washington Post. All of these outlets published consistent information about the same FDA approval, on the same day. Most importantly, the FDA itself published an official press release on its website on May 16, 2025, clearly stating that the Lumipulse test by Fujirebio Diagnostics has been cleared for use in diagnosing Alzheimer’s disease. The presence of this direct confirmation from the FDA proves without a doubt that the news is real and trustworthy. Sources:- FDA Official Statement: https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease
- Reuters: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-clears-first-blood-test-detect-alzheimers-disease-2025-05-16/
- AP News: https://apnews.com/article/alzheimers-blood-test-fda-leqembi-kisunla-ad3cffe0bd540accf47e8ee105b439a9
- The Washington Post: https://www.washingtonpost.com/business/2025/05/16/alzheimers-blood-test-fda-approved/
